1 Study Coverage 1.1 Hereditary Cancer Testing Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Introduction 1.2 Global Hereditary Cancer Testing Outlook 2017 VS 2022 VS 2028 1.2.1 Global Hereditary Cancer Testing Market Size for the Year 2017-2028 1.2.2 Global Hereditary Cancer Testing Market Size for the Year 2017-2028 1.3 Hereditary Cancer Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Hereditary Cancer Testing in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Hereditary Cancer Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Hereditary Cancer Testing Market Dynamics 1.4.1 Hereditary Cancer Testing Industry Trends 1.4.2 Hereditary Cancer Testing Market Drivers 1.4.3 Hereditary Cancer Testing Market Challenges 1.4.4 Hereditary Cancer Testing Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Hereditary Cancer Testing by Type 2.1 Hereditary Cancer Testing Market Segment by Type 2.1.1 RNA Testing 2.1.2 DNA Testing 2.2 Global Hereditary Cancer Testing Market Size by Type (2017, 2022 & 2028) 2.3 Global Hereditary Cancer Testing Market Size by Type (2017-2028) 2.4 United States Hereditary Cancer Testing Market Size by Type (2017, 2022 & 2028) 2.5 United States Hereditary Cancer Testing Market Size by Type (2017-2028) 3 Hereditary Cancer Testing by Application 3.1 Hereditary Cancer Testing Market Segment by Application 3.1.1 Breast Cancer 3.1.2 Gastrointestinal Cancer 3.1.3 Prostate Cancer 3.1.4 Respiratory/Lung Cancer 3.1.5 Other Cancers 3.2 Global Hereditary Cancer Testing Market Size by Application (2017, 2022 & 2028) 3.3 Global Hereditary Cancer Testing Market Size by Application (2017-2028) 3.4 United States Hereditary Cancer Testing Market Size by Application (2017, 2022 & 2028) 3.5 United States Hereditary Cancer Testing Market Size by Application (2017-2028) 4 Global Hereditary Cancer Testing Competitor Landscape by Company 4.1 Global Hereditary Cancer Testing Market Size by Company 4.1.1 Top Global Hereditary Cancer Testing Companies Ranked by Revenue (2021) 4.1.2 Global Hereditary Cancer Testing Revenue by Player (2017-2022) 4.2 Global Hereditary Cancer Testing Concentration Ratio (CR) 4.2.1 Hereditary Cancer Testing Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Hereditary Cancer Testing in 2021 4.2.3 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Hereditary Cancer Testing Headquarters, Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Type 4.3.1 Global Hereditary Cancer Testing Headquarters and Area Served 4.3.2 Global Hereditary Cancer Testing Companies Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Hereditary Cancer Testing Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Hereditary Cancer Testing Market Size by Company 4.5.1 Top Hereditary Cancer Testing Players in United States, Ranked by Revenue (2021) 4.5.2 United States Hereditary Cancer Testing Revenue by Players (2020, 2021 & 2022) 5 Global Hereditary Cancer Testing Market Size by Region 5.1 Global Hereditary Cancer Testing Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Hereditary Cancer Testing Market Size by Region (2017-2028) 5.2.1 Global Hereditary Cancer Testing Market Size by Region: 2017-2022 5.2.2 Global Hereditary Cancer Testing Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Hereditary Cancer Testing Market Size YoY Growth 2017-2028 6.1.2 North America Hereditary Cancer Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Hereditary Cancer Testing Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Hereditary Cancer Testing Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Hereditary Cancer Testing Market Size YoY Growth 2017-2028 6.3.2 Europe Hereditary Cancer Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Hereditary Cancer Testing Market Size YoY Growth 2017-2028 6.4.2 Latin America Hereditary Cancer Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Hereditary Cancer Testing Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Hereditary Cancer Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Ambry Genetics (Konica Minota) 7.1.1 Ambry Genetics (Konica Minota) Company Details 7.1.2 Ambry Genetics (Konica Minota) Business Overview 7.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction 7.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2017-2022) 7.1.5 Ambry Genetics (Konica Minota) Recent Development 7.2 Asper Biogene 7.2.1 Asper Biogene Company Details 7.2.2 Asper Biogene Business Overview 7.2.3 Asper Biogene Hereditary Cancer Testing Introduction 7.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2017-2022) 7.2.5 Asper Biogene Recent Development 7.3 Natera 7.3.1 Natera Company Details 7.3.2 Natera Business Overview 7.3.3 Natera Hereditary Cancer Testing Introduction 7.3.4 Natera Revenue in Hereditary Cancer Testing Business (2017-2022) 7.3.5 Natera Recent Development 7.4 Caris Life Sciences 7.4.1 Caris Life Sciences Company Details 7.4.2 Caris Life Sciences Business Overview 7.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction 7.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) 7.4.5 Caris Life Sciences Recent Development 7.5 BioReference Laboratories (GeneDx) 7.5.1 BioReference Laboratories (GeneDx) Company Details 7.5.2 BioReference Laboratories (GeneDx) Business Overview 7.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction 7.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2017-2022) 7.5.5 BioReference Laboratories (GeneDx) Recent Development 7.6 LabSolutions 7.6.1 LabSolutions Company Details 7.6.2 LabSolutions Business Overview 7.6.3 LabSolutions Hereditary Cancer Testing Introduction 7.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2017-2022) 7.6.5 LabSolutions Recent Development 7.7 Progenity，Inc 7.7.1 Progenity，Inc Company Details 7.7.2 Progenity，Inc Business Overview 7.7.3 Progenity，Inc Hereditary Cancer Testing Introduction 7.7.4 Progenity，Inc Revenue in Hereditary Cancer Testing Business (2017-2022) 7.7.5 Progenity，Inc Recent Development 7.8 ARUP Laboratories 7.8.1 ARUP Laboratories Company Details 7.8.2 ARUP Laboratories Business Overview 7.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction 7.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2017-2022) 7.8.5 ARUP Laboratories Recent Development 7.9 Myriad 7.9.1 Myriad Company Details 7.9.2 Myriad Business Overview 7.9.3 Myriad Hereditary Cancer Testing Introduction 7.9.4 Myriad Revenue in Hereditary Cancer Testing Business (2017-2022) 7.9.5 Myriad Recent Development 7.10 NeoGenomics 7.10.1 NeoGenomics Company Details 7.10.2 NeoGenomics Business Overview 7.10.3 NeoGenomics Hereditary Cancer Testing Introduction 7.10.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2017-2022) 7.10.5 NeoGenomics Recent Development 7.11 Blueprint Genetics 7.11.1 Blueprint Genetics Company Details 7.11.2 Blueprint Genetics Business Overview 7.11.3 Blueprint Genetics Hereditary Cancer Testing Introduction 7.11.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) 7.11.5 Blueprint Genetics Recent Development 7.12 CellMax Life 7.12.1 CellMax Life Company Details 7.12.2 CellMax Life Business Overview 7.12.3 CellMax Life Hereditary Cancer Testing Introduction 7.12.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2017-2022) 7.12.5 CellMax Life Recent Development 7.13 Fulgent Genetics 7.13.1 Fulgent Genetics Company Details 7.13.2 Fulgent Genetics Business Overview 7.13.3 Fulgent Genetics Hereditary Cancer Testing Introduction 7.13.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) 7.13.5 Fulgent Genetics Recent Development 7.14 Strand Life Sciences 7.14.1 Strand Life Sciences Company Details 7.14.2 Strand Life Sciences Business Overview 7.14.3 Strand Life Sciences Hereditary Cancer Testing Introduction 7.14.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) 7.14.5 Strand Life Sciences Recent Development 7.15 Myogenes 7.15.1 Myogenes Company Details 7.15.2 Myogenes Business Overview 7.15.3 Myogenes Hereditary Cancer Testing Introduction 7.15.4 Myogenes Revenue in Hereditary Cancer Testing Business (2017-2022) 7.15.5 Myogenes Recent Development 7.16 LabCorp 7.16.1 LabCorp Company Details 7.16.2 LabCorp Business Overview 7.16.3 LabCorp Hereditary Cancer Testing Introduction 7.16.4 LabCorp Revenue in Hereditary Cancer Testing Business (2017-2022) 7.16.5 LabCorp Recent Development 7.17 Quest Diagnostics 7.17.1 Quest Diagnostics Company Details 7.17.2 Quest Diagnostics Business Overview 7.17.3 Quest Diagnostics Hereditary Cancer Testing Introduction 7.17.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2017-2022) 7.17.5 Quest Diagnostics Recent Development 7.18 Pathway Genomics 7.18.1 Pathway Genomics Company Details 7.18.2 Pathway Genomics Business Overview 7.18.3 Pathway Genomics Hereditary Cancer Testing Introduction 7.18.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2017-2022) 7.18.5 Pathway Genomics Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Hereditary Cancer Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Hereditary Cancer Testing Market Trends Table 3. Hereditary Cancer Testing Market Drivers Table 4. Hereditary Cancer Testing Market Challenges Table 5. Hereditary Cancer Testing Market Restraints Table 6. Global Hereditary Cancer Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Hereditary Cancer Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Hereditary Cancer Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Hereditary Cancer Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Hereditary Cancer Testing Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Hereditary Cancer Testing Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Hereditary Cancer Testing Revenue Share by Player, 2017-2022 Table 13. Global Hereditary Cancer Testing Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Hereditary Cancer Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2021) Table 15. Top Players of Hereditary Cancer Testing in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Hereditary Cancer Testing Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Hereditary Cancer Testing Players in United States Market, Ranking by Revenue (2021) Table 20. United States Hereditary Cancer Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Hereditary Cancer Testing Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Hereditary Cancer Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Hereditary Cancer Testing Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Hereditary Cancer Testing Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Hereditary Cancer Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Hereditary Cancer Testing Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Hereditary Cancer Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Hereditary Cancer Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Hereditary Cancer Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Ambry Genetics (Konica Minota) Company Details Table 31. Ambry Genetics (Konica Minota) Business Overview Table 32. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product Table 33. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 34. Ambry Genetics (Konica Minota) Recent Development Table 35. Asper Biogene Company Details Table 36. Asper Biogene Business Overview Table 37. Asper Biogene Hereditary Cancer Testing Product Table 38. Asper Biogene Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 39. Asper Biogene Recent Development Table 40. Natera Company Details Table 41. Natera Business Overview Table 42. Natera Hereditary Cancer Testing Product Table 43. Natera Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 44. Natera Recent Development Table 45. Caris Life Sciences Company Details Table 46. Caris Life Sciences Business Overview Table 47. Caris Life Sciences Hereditary Cancer Testing Product Table 48. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 49. Caris Life Sciences Recent Development Table 50. BioReference Laboratories (GeneDx) Company Details Table 51. BioReference Laboratories (GeneDx) Business Overview Table 52. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product Table 53. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 54. BioReference Laboratories (GeneDx) Recent Development Table 55. LabSolutions Company Details Table 56. LabSolutions Business Overview Table 57. LabSolutions Hereditary Cancer Testing Product Table 58. LabSolutions Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 59. LabSolutions Recent Development Table 60. Progenity，Inc Company Details Table 61. Progenity，Inc Business Overview Table 62. Progenity，Inc Hereditary Cancer Testing Product Table 63. Progenity，Inc Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 64. Progenity，Inc Recent Development Table 65. ARUP Laboratories Company Details Table 66. ARUP Laboratories Business Overview Table 67. ARUP Laboratories Hereditary Cancer Testing Product Table 68. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 69. ARUP Laboratories Recent Development Table 70. Myriad Company Details Table 71. Myriad Business Overview Table 72. Myriad Hereditary Cancer Testing Product Table 73. Myriad Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 74. Myriad Recent Development Table 75. NeoGenomics Company Details Table 76. NeoGenomics Business Overview Table 77. NeoGenomics Hereditary Cancer Testing Product Table 78. NeoGenomics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 79. NeoGenomics Recent Development Table 80. Blueprint Genetics Company Details Table 81. Blueprint Genetics Business Overview Table 82. Blueprint Genetics Hereditary Cancer Testing Product Table 83. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 84. Blueprint Genetics Recent Development Table 85. CellMax Life Company Details Table 86. CellMax Life Business Overview Table 87. CellMax Life Hereditary Cancer Testing Product Table 88. CellMax Life Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 89. CellMax Life Recent Development Table 90. Fulgent Genetics Company Details Table 91. Fulgent Genetics Business Overview Table 92. Fulgent Genetics Hereditary Cancer Testing Product Table 93. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 94. Fulgent Genetics Recent Development Table 95. Strand Life Sciences Company Details Table 96. Strand Life Sciences Business Overview Table 97. Strand Life Sciences Hereditary Cancer Testing Product Table 98. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 99. Strand Life Sciences Recent Development Table 100. Myogenes Company Details Table 101. Myogenes Business Overview Table 102. Myogenes Hereditary Cancer Testing Product Table 103. Myogenes Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 104. Myogenes Recent Development Table 105. LabCorp Company Details Table 106. LabCorp Business Overview Table 107. LabCorp Hereditary Cancer Testing Product Table 108. LabCorp Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 109. LabCorp Recent Development Table 110. Quest Diagnostics Company Details Table 111. Quest Diagnostics Business Overview Table 112. Quest Diagnostics Hereditary Cancer Testing Product Table 113. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 114. Quest Diagnostics Recent Development Table 115. Pathway Genomics Company Details Table 116. Pathway Genomics Business Overview Table 117. Pathway Genomics Hereditary Cancer Testing Product Table 118. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 119. Pathway Genomics Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Hereditary Cancer Testing Product Picture Figure 2. Global Hereditary Cancer Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Hereditary Cancer Testing Market Size 2017-2028 (US$ Million) Figure 4. United States Hereditary Cancer Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Hereditary Cancer Testing Market Size 2017-2028 (US$ Million) Figure 6. United States Hereditary Cancer Testing Market Share in Global 2017-2028 Figure 7. Hereditary Cancer Testing Report Years Considered Figure 8. Product Picture of RNA Testing Figure 9. Product Picture of DNA Testing Figure 10. Global Hereditary Cancer Testing Market Share by Type in 2022 & 2028 Figure 11. Global Hereditary Cancer Testing Market Size by Type (2017-2028) & (US$ Million) Figure 12. Global Hereditary Cancer Testing Market Share by Type (2017-2028) Figure 13. United States Hereditary Cancer Testing Market Share by Type in 2022 & 2028 Figure 14. United States Hereditary Cancer Testing Market Size by Type (2017-2028) & (US$ Million) Figure 15. United States Hereditary Cancer Testing Market Share by Type (2017-2028) Figure 16. Product Picture of Breast Cancer Figure 17. Product Picture of Gastrointestinal Cancer Figure 18. Product Picture of Prostate Cancer Figure 19. Product Picture of Respiratory/Lung Cancer Figure 20. Product Picture of Other Cancers Figure 21. Global Hereditary Cancer Testing Market Share by Application in 2022 & 2028 Figure 22. Global Hereditary Cancer Testing Market Size by Application (2017-2028) & (US$ Million) Figure 23. Global Hereditary Cancer Testing Market Share by Application (2017-2028) Figure 24. United States Hereditary Cancer Testing Market Share by Application in 2022 & 2028 Figure 25. United States Hereditary Cancer Testing Market Size by Application (2017-2028) & (US$ Million) Figure 26. United States Hereditary Cancer Testing Market Share by Application (2017-2028) Figure 27. North America Hereditary Cancer Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 28. U.S. Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. Canada Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Europe Hereditary Cancer Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 31. Germany Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. France Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. U.K. Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Italy Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Russia Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Asia-Pacific Hereditary Cancer Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 37. China Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Japan Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. South Korea Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. India Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Australia Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Taiwan Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Indonesia Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Thailand Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Malaysia Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Philippines Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Latin America Hereditary Cancer Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 48. Mexico Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Brazil Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Argentina Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Middle East & Africa Hereditary Cancer Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 52. Turkey Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Saudi Arabia Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. U.A.E Hereditary Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. Ambry Genetics (Konica Minota) Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 56. Asper Biogene Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 57. Natera Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 58. Caris Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 59. BioReference Laboratories (GeneDx) Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 60. LabSolutions Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 61. Progenity，Inc Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 62. ARUP Laboratories Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 63. Myriad Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 64. NeoGenomics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 65. Blueprint Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 66. CellMax Life Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 67. Fulgent Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 68. Strand Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 69. Myogenes Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 70. LabCorp Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 71. Quest Diagnostics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 72. Pathway Genomics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Ambry Genetics (Konica Minota) Asper Biogene Natera Caris Life Sciences BioReference Laboratories (GeneDx) LabSolutions Progenity，Inc ARUP Laboratories Myriad NeoGenomics Blueprint Genetics CellMax Life Fulgent Genetics Strand Life Sciences Myogenes LabCorp Quest Diagnostics Pathway Genomics